ARGX-213 tested in healthy volunteers for safety
NCT ID NCT06968338
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed phase 1 trial tested the safety of ARGX-213 in 88 healthy adults aged 18 to 65. Participants received either the drug or a placebo, and researchers monitored side effects, drug levels in the blood, and immune responses over up to 21 weeks. The study aims to understand how ARGX-213 behaves in the body before any future disease-focused trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ARGX-213
What could go wrong
This is an early phase 1 study in healthy volunteers, so it does not test any disease treatment. The results only show safety and how the drug moves in the body, not whether it works for any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences
Montreal, QC H3P 3P1, Canada